These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16477550)
1. Treatment of first recurrences of Clostridium difficile-associated disease: waiting for new treatment options. Louie TJ Clin Infect Dis; 2006 Mar; 42(6):765-7. PubMed ID: 16477550 [No Abstract] [Full Text] [Related]
2. The changing face of Clostridium difficile: what treatment options remain? Shen EP; Surawicz CM Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108 [TBL] [Abstract][Full Text] [Related]
3. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Pépin J; Routhier S; Gagnon S; Brazeau I Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549 [TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea. Stepan C; Surawicz CM Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327 [TBL] [Abstract][Full Text] [Related]
7. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec. Weiss K Clin Infect Dis; 2006 Mar; 42(5):725-7; author reply 727-9. PubMed ID: 16447121 [No Abstract] [Full Text] [Related]
8. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004. Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347 [TBL] [Abstract][Full Text] [Related]
9. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Valiquette L; Cossette B; Garant MP; Diab H; Pépin J Clin Infect Dis; 2007 Sep; 45 Suppl 2():S112-21. PubMed ID: 17683015 [TBL] [Abstract][Full Text] [Related]
13. Reining in recurrent Clostridium difficile infection--who's at risk? Surawicz CM Gastroenterology; 2009 Apr; 136(4):1152-4. PubMed ID: 19250653 [No Abstract] [Full Text] [Related]
14. UK launches inquiry into Clostridium difficile outbreak. Katikireddi V CMAJ; 2005 Jul; 173(2):138. PubMed ID: 16027424 [No Abstract] [Full Text] [Related]
15. Treatment of clostridium difficile colitis in the critical care setting. Musher DM; Aslam S Crit Care Clin; 2008 Apr; 24(2):279-91, viii. PubMed ID: 18361946 [TBL] [Abstract][Full Text] [Related]
16. Update on the changing epidemiology of Clostridium difficile-associated disease. McFarland LV Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906 [TBL] [Abstract][Full Text] [Related]
17. Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies. McFarland LV Curr Opin Gastroenterol; 2009 Jan; 25(1):24-35. PubMed ID: 19114771 [TBL] [Abstract][Full Text] [Related]
18. C. difficile strain 20 times more virulent. Eggertson L CMAJ; 2005 May; 172(10):1279. PubMed ID: 15883397 [No Abstract] [Full Text] [Related]
19. Clostridium difficile-associated disease. Heins JR S D Med; 2006 Dec; 59(12):515-7. PubMed ID: 17212182 [No Abstract] [Full Text] [Related]
20. Recent advances in Clostridium difficile-associated disease. Monaghan T; Boswell T; Mahida YR Postgrad Med J; 2009 Mar; 85(1001):152-62. PubMed ID: 19351643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]